Comparing Everolimus to Sunitinib in Non-clear-cell Renal Cell Carcinoma

被引：3
|
作者：
Bex, Axel [1 ]
Ljungberg, Borje [2 ]
机构：
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Urol, Amsterdam, Netherlands
[2] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, SE-90185 Umea, Sweden
来源：
EUROPEAN UROLOGY | 2016年 / 69卷 / 05期
关键词：
PHASE-II; TRIAL;
D O I：
10.1016/j.eururo.2015.11.013
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：875 / 876
页数：2
相关论文
共 50 条
  • [1] Sunitinib versus everolimus for non-clear-cell renal cell carcinoma
    Rebecca Kelsey
    Nature Reviews Urology, 2016, 13 (3) : 124 - 124
  • [2] Chemotherapy for non-clear-cell renal cell carcinoma
    David, Kevin A.
    Milowsky, Matthew I.
    Nanus, David M.
    CLINICAL GENITOURINARY CANCER, 2006, 4 (04) : 263 - 268
  • [3] Combination therapies in non-clear-cell renal cell carcinoma
    Aslan, Volkan
    Ozdemir, Nuriye
    Yazici, Ozan
    Ozet, Ahmet
    LANCET ONCOLOGY, 2023, 24 (10): : E401 - E401
  • [4] Everolimus versus sunitinib for patients with metastatic non-clear-cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
    Armstrong, Andrew J.
    Halabi, Susan
    Eisen, Tim
    Broderick, Samuel
    Stadler, Walter M.
    Jones, Robert J.
    Garcia, Jorge A.
    Vaishampayan, Ulka N.
    Picus, Joel
    Hawkins, Robert E.
    Hainsworth, John D.
    Kollmannsberger, Christian K.
    Logan, Theodore F.
    Puzanov, Igor
    Pickering, Lisa M.
    Ryan, Christopher W.
    Protheroe, Andrew
    Lusk, Christine M.
    Oberg, Sadie
    George, Daniel J.
    LANCET ONCOLOGY, 2016, 17 (03): : 378 - 388
  • [5] Developing a Clear Path Forward for Non-Clear-Cell Renal Carcinoma
    Pal, Sumanta K.
    Karam, Jose A.
    Bergerot, Paulo
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (32) : 3825 - +
  • [6] Non-clear-cell renal carcinoma therapy: handle with care
    Buti, Sebastiano
    Bersanelli, Melissa
    LANCET ONCOLOGY, 2016, 17 (03): : 270 - 271
  • [7] A well organised effort to metastatic non-clear-cell renal cell carcinoma
    Russo, Paul
    LANCET ONCOLOGY, 2019, 20 (04): : 472 - 473
  • [8] The Efficacy of Lenvatinib and Everolimus in Chromophobe-type Non-Clear-Cell Renal Cell Carcinoma: A Case Report and Literature Review
    Schwartz, Candice
    Pfanzelter, Nicklas
    Kuzel, Timothy M.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (05) : E903 - E906
  • [9] Cabozantinib in advanced non-clear-cell renal cell carcinoma: is it the way clearer now?
    Di Pierro, Giulia
    Mini, Enrico
    Roviello, Giandomenico
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [10] Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell carcinoma (RCC)
    Aizer, Ayal A.
    Urun, Yuksel
    McKay, Rana R.
    Kibel, Adam S.
    Nguyen, Paul L.
    Choueiri, Toni K.
    BJU INTERNATIONAL, 2014, 113 (5B) : E67 - E74
12345